Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1V47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,955
Award facts
- Contract value 100% obligated
- $38,955.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,955.28 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL unit doses. This is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded without set-aside restrictions, demonstrating AmerisourceBergen's ability to meet federal procurement requirements in open competition.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products to military and veteran healthcare systems through the DLA Medical Supply Chain. Zepbound, a diabetes and weight management medication, aligns with the company's portfolio of specialty medications and chronic disease treatments delivered under its federal contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F1V47?
SPE2DR26F1V47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1V47 worth?
The government has obligated $38,955 on SPE2DR26F1V47.
Is contract SPE2DR26F1V47 an order under another contract?
Yes. SPE2DR26F1V47 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V47 competed?
The extent of competition for SPE2DR26F1V47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award